Reproterol - A monomolecular combination of orciprenaline and theophylline: Novel aspects of its mode of action in asthma

Respiration

Volumn 66, Issue 3, 1999, Pages 220-224

  Juergens, Uwe R ^a   Stöber, Meinolf ^a   Vetter, Hans ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

cAMP; Leukotriene B4; Orciprenaline; Reproterol; Theophylline

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BRONCHODILATING AGENT; CYCLIC AMP; LEUKOTRIENE B4; LIPOPOLYSACCHARIDE; ORCIPRENALINE; PROPRANOLOL; REPROTEROL; THEOPHYLLINE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; ICOSANOID METABOLISM; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; BRONCHODILATOR AGENTS; CYCLIC AMP; DRUG COMBINATIONS; HUMANS; LEUKOTRIENE B4; ORCIPRENALINE; REFERENCE VALUES; THEOPHYLLINE;

EID: 0345280738     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029381     Document Type: Article

References (27)

1. Church MK, Hiroi J: Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol 1987;90:421-429.
2. 2-Agonists in Asthma Treatment. New York, Dekker, 1997, pp 36-66.
3. 2-adrenoceptor-stimulating drugs; in Pauwels R, O'Byrne PM (eds): p2-Agonists in Asthma Treatment. New York, Dekker, 1997, pp 87-130,
4. Torphy TJ: Phosphodiesterase isozymes: Molecular targets for novel antiasthma agents. Am J Respir Crit Care Med 1998;157:351-370.
5. Habersang S, Leuschner F, von Schlichtegroll A: Toxicological investigation of reproterol (in German). Arzneimittelforschung 1977;27:45-52.
6. Barnes PJ, Pauwels RA: Theophylline in the management of asthma: Time for reappraisal? Eur Respir J 1994;7:579-591.
7. 2-Adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline treated patients. Chest 1990;98:376-381.
8. Liggett SB, Marker JC, Shah SD, Roper CL, Cryer PE: Direct relationship between mononuclear leukocyte and lung β-adrenergic receptors and apparent reciprocal regulation of extravascular but not intravascular alpha and beta-adrenergic receptors via the sympathochromaffin system in humans. J Clin Invest 1988;82:48-56.
9. Greten TF, Sinha B, Haslberger C, Eigler A, Endres S: Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-α synthesis. Eur J Pharmacol 1996;299:229-233.
10. Tenor H, Hatzelmann A, Kupferschmidt R, Stanciu L, Djukanovic R, Schudt C, Wendel A, Church MK, Shute JK: Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar raacrophages. Clin Exp Allergy 1995; 25:625-633.
11. Boyum A: Isolation of human monocytes with Nycodenz, a new non-ionic iodinated gradient medium. Scand J Immunol 1983;17:429-436.
12. Juergens UR, Christiansen SC, Stevenson DD, Zuraw BL: Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge. J Allergy Clin Immunol 1992;90:636-645.
13. Szentivanyi A: The β-adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 1968;42:203-232.
14. Dooper MWSM, Timmermans A, Aalbers R, De Monchy JGR, Kauffman HF: Desensitisation of the adenylyl-cyclase system in peripheral blood mononuclear cells from patients with asthma three hours after allergen challenge. J Allergy Clin Immunol 1993;92:559-566.
15. Grove A, Lipworth BJ: Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet 1995;346: 201-206.
16. Manning CD, McLaughlin MM, Livi GP, Cieslinski LB, Torphy TJ, Barnette MS: Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B. J Pharmacol Exp Ther 1996;276:810-818.
17. Torphy TJ, Zhou HL, Cieslinski LB: Stimulation of β-adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity. J Pharmacol Exp Ther 1992;263:1195-1205.
18. Marmo E, Di Mezza F, Giordano L, Matera MG, De Carlo R, Ruggiero E: In vitro effect of reproterol upon pulmonary, cardiac, vascular and intestinal 3′,5′-monophosphate phosphodiesterase nucleoside. J Pharm Pharmacol 1982;34:342-343.
19. Fairfax AJ, Rehahn M, Jones D, O'Malley B: Comparison between the effects of inhaled isoprenaline and fenoterol on plasma cyclic AMP and heart rate in normal subjects. Br J Clin Pharmacol 1984;17:165-170.
20. Raij K, Muittari A, Harkonen M: Effect of salbutamol inhalations on plasma and urinary cyclic adenosine monophosphate levels in asthmatics and non-atopic controls. Scand J Respir Dis 1976;57:223-230.
21. Mitchell HW, Hau H, Denborough MA: In vitro action of combined salbutamol and theophylline on anaphylactic contractions, mediator release and cyclic 3′,5′-adenosine monophosphate in lung parenchyma. Eur J Pharmacol 1979;57:399-406.
22. Vigano T, Sautebin L, Crivellari MT, Galli G, Mezzetti M, Folco GC: Effect of the beta-2 adrenergic agonist fenoterol on the release of leukotrienes and prostaglandin D2 from human lung parenchyma. Wien Klin Wochenschr 1986;98:120-122.
23. Hughes JM, Scale JP, Temple DM: Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: Selective antagonism by β-adrenoceptor antagonists. Eur J Pharmacol 1983;95:239-245.
24. Mandi A, Wilde W, Galgoczy G, Aurich R, Galambos E: Studies on the onset of effect of reproterol following inhalation from a metered aerosol (in German). Arzneimittelforschung 1977;27:64-66.
25. Mandi A, Galfoczy G, Galambos E: On the bronchodilatory effect of reproterol (in German). Arzneimittelforschung 1977;27:60-63.
26. Tabori D, Conkic B, Todic V, Mijatovic M, Mirkovc S, Zecevic D, Camprag D: The bronchodilating action of reproterol in patients with bronchial asthma and chronic obstructive bronchitis (in German). Arzneimittelforschung 1977;27:55-60.
27. Higgs CM, Laszlo G: The duration of protection from exercise-induced asthma by inhaled salbutamol, and a comparison with inhaled reproterol. Br J Dis Chest 1983;77:262-269.